Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02624050 · ClinicalTrials.gov registry record · NA
Methohexital v Propofol as General Anesthetic in Patients on ACEIs or ARBs
A NA study of Anesthesia and Hypotension, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 51
- Enrollment target
- 1
- Study location
NCT02624050: Completed NA study of Anesthesia and Hypotension, sponsored by Milton S. Hershey Medical Center.
NCT02624050 is a NA study of Anesthesia and Hypotension that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 51 participants, below the 109,409-participant average among 57 other Anesthesia trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02624050, a NA study of Anesthesia and Hypotension, has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 51 participants
- Enrollment target
- 1
- Study location
Study Summary
Patient undergoing general anesthesia in elective surgery will be assigned to receive either methohexital or propofol general anesthesia. Hypotensive events during the first 15 minutes of induction will be compared between the groups to ascertain which drug is less likely to cause a hypotensive event.
Primary Outcome
Hypotensive events under either methohexital or propofol general anesthesia will be counted as the primary outcome measure
Conditions Studied
Interventions
- DRUG Propofol
- DRUG Methohexital
Study Locations (1)
Pennsylvania
- Penn State Milton S Hershey Medical Ctr - Hershey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2016-08-01 |
| Est. Completion | 2018-01-31 |
| Phase | NA |
What the finished NCT02624050 record still lists
NCT02624050 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 51 participants, a relatively small participant target, below the 109,409-participant average among 57 other Anesthesia trials with a reported enrollment target (100% lower).
The record links to 2 conditions, with Anesthesia appearing as the primary indexed condition, and to 2 interventions - of which Propofol is the first listed.
NCT02624050 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02624050 about?
NCT02624050 is a clinical study titled "Methohexital v Propofol as General Anesthetic in Patients on ACEIs or ARBs". Patient undergoing general anesthesia in elective surgery will be assigned to receive either methohexital or propofol general anesthesia. Hypotensive events during the first 15 minutes of induction will be compared between the groups to ascertain which drug is less likely to cause a hypotensive even...
What is the current status of trial NCT02624050?
This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2016-08-01. Estimated completion is 2018-01-31.
What conditions does trial NCT02624050 study?
This clinical trial studies the following conditions: Anesthesia, Hypotension.
What interventions are being tested in trial NCT02624050?
The interventions under investigation include: Propofol (DRUG), Methohexital (DRUG).
Who is sponsoring clinical trial NCT02624050?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02624050 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anesthesia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02624050's enrollment target sits among peer trials
51 35th of 57 higher than 23 of 57 other Anesthesia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anesthesia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial
RECRUITING · NA
-
Opioid Sparing Anesthesia Care for Pediatric Patients Having Tonsil Surgery
RECRUITING · NA
-
Pilot Feasibility Trial of the SafeLM Supraglottic Airway (SGA)
RECRUITING · NA
-
Enhanced Recovery After Surgery (ERAS) Total Knee Replacement (TKR) With a Transitional Pain Service
RECRUITING · NA
-
REcovery From DEXmedetomidine-induced Unconsciousness
RECRUITING · NA
-
Poke and a Placebo
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI